NewslettersProstate Cell NewsRational Design and Development of Selective BRD7 Bromodomain Inhibitors and Their Activity in Prostate CancerBy Laurisa Dohm - August 11, 20230166Researchers validated the utility and selectivity of the compounds developped in cell-based models of prostate cancer.[Journal Of Medicinal Chemistry]AbstractGraphical Abstract